SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News

ETF Overview

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Key Stats

• Today's Range: $47.06 to $47.41
• 50-Day Range: $40.58 to $47.32
• 52-Week Range: $35.22 to $48.76
• Volume: 46,050 shs
• Average Volume: 48,717 shs
• Market Capitalization: $170.01 million
• Assets Under Management: $186.81 million
• Dividend Yield: 1.25%
• Net Expense Ratio: 0.35%
• Aggregate Rating: Moderate Buy

XPH ETF - Frequently Asked Questions

How have XPH shares performed this year?

SPDR S&P Pharmaceuticals ETF's stock was trading at $42.99 at the beginning of 2025. Since then, XPH shares have increased by 9.9% and is now trading at $47.2250.

Who are SPDR S&P Pharmaceuticals ETF's major shareholders?

Top institutional investors of SPDR S&P Pharmaceuticals ETF include Bank of America Corp DE (18.35%), Kingsview Wealth Management LLC (6.58%), First Citizens Bank & Trust Co. (4.90%) and Envestnet Portfolio Solutions Inc. (4.47%).

How do I buy shares of SPDR S&P Pharmaceuticals ETF?

Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Pharmaceuticals ETF investors own include NVIDIA (NVDA), Pfizer (PFE), Adobe (ADBE), Applied Materials (AMAT), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Meta Platforms (META).

Fund Details

• Issuer: SSgA
• Fund Name: SPDR S&P Pharmaceuticals ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:XPH
• Inception Date: 6/19/2006
• Fund Manager: Michael Feehily, Karl Schneider, Keith Richardson
• Web: www.spdrs.com
• Phone: +1-617-6644738

Fund Focus

• Asset Class: Equity
• Benchmark: S&P Pharmaceuticals Select Industry Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 54

Fund Statistics

• Assets Under Management: $183.63 million
• Average Daily Volume: $48.68 thousand
• Discount/Premium: 0.04%

Administrator, Advisor and Custodian

• Administrator: SSgA Funds Management, Inc.
• Advisor: SSgA Funds Management, Inc.
• Custodian: State Street Bank and Trust Company
• Distributor: State Street Global Advisors Funds Distributors, LLC
• Transfer Agent: State Street Bank and Trust Company
• Trustee: N/A
• Lead Market Maker: Citadel

Options

• Optionable: Optionable
• Options Volume: 1
• Put Options: 1
• Call Options: 5
• Short Interest: 992,700 shs

Miscellaneous

• Outstanding Shares: 3,600,000
• Beta: 0.84
• Creation Unit: 50,000
• Creation Fee: $250.00